SEARCH

SEARCH BY CITATION

References

  • 1
    Sambrook P, Cooper C. Osteoporosis. Lancet. 2006; 367: 20108.
  • 2
    Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics. 2010; 28: 395409.
  • 3
    Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2010; 153: 99111.
  • 4
    Ensrud KE, Lui L-Y, Taylor BC, Schousboe JT, Donaldson MG, Fink HA, Cauley JA, Hillier TA, Browner WS, Cummings SR; for the Study of Osteoporotic Fractures Research Group. A comparison of prediction models for fractures in older women: is more better? Arch Intern Med. 2009; 169: 208794.
  • 5
    Sandhu S, Nguyen N, Center J, Pocock N, Eisman J, Nguyen T. Prognosis of fracture: evaluation of predictive accuracy of the FRAX™ algorithm and Garvan nomogram. Osteoporos Int. 2010; 21: 86371.
  • 6
    Silverman S, Calderon A. The utility and limitations of FRAX: A US perspective. Curr Osteoporos Rep. 2010; 8: 1927.
  • 7
    Siris ES, Chen Y-T, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004; 164: 110812.
  • 8
    Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; 359: 17617.
  • 9
    Michaëlsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL. Genetic liability to fractures in the elderly. Arch Intern Med. 2005; 165: 182530.
  • 10
    Nuti R, Merlotti D, Francucci CM, Gennari L. Bone fragility in men: where are we? J Endocrinol Invest. 2010; 33: 338.
  • 11
    Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. Summary of the Updated American Geriatrics Society/British Geriatrics Society Clinical Practice Guideline for Prevention of Falls in Older Persons. J Am Geriatr Soc. 2011; 59: 14857.
  • 12
    Järvinen TLN, Sievänen H, Khan KM, Heinonen A, Kannus P. Shifting the focus in fracture prevention from osteoporosis to falls. BMJ. 2008; 336: 1246.
  • 13
    Oliver D, Connelly JB, Victor CR, Shaw FE, Whitehead A, Genc Y, Vanoli A, Martin FC, Gosney MA. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ. 2007; 334: 82.
  • 14
    Robertson MC, Campbell AJ, Gardner MM, Devlin N. Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data. J Am Geriatr Soc. 2002; 50: 90511.
  • 15
    Sawka AM, Boulos P, Beattie K, Papaioannou A, Gafni A, Cranney A, Hanley DA, Adachi JD, Papadimitropoulos EA, Thabane L. Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis. J Clin Epidemiol. 2007; 60: 33644.
  • 16
    Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ. 2005; 331: 1374.
  • 17
    Farahmand BY, Persson PG, Michaëlsson K, Baron JA, Parker MG, Ljunghall S; for the Swedish Hip Fracture Study Group. Socioeconomic status, marital status and hip fracture risk: a population-based case–control study. Osteoporos Int. 2000; 11: 80338.
  • 18
    Michaëlsson K, Olofsson H, Jensevik K, Larsson S, Mallmin H, Berglund L, Vessby B, Melhus H. Leisure physical activity and the risk of fracture in men. PLoS Med. 2007; 4: e199.
  • 19
    Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E. FRAX® and its applications to clinical practice. Bone. 2009; 44: 73443.
  • 20
    Kanis JA; on behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level. Technical Report. Sheffield, UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield; 2007.
  • 21
    Byberg L, Melhus H, Gedeborg R, Sundström J, Ahlbom A, Zethelius B, Berglund LG, Wolk A, Michaëlsson K. Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ. 2009; 338: b688.
  • 22
    Kanis J, Johnell O, Oden A, Johansson H, McCloskey E. FRAX™ and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008; 19: 38597.
  • 23
    Kanis J, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman J, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton L, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts N, Yoshimura N. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18: 103346.
  • 24
    Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998; 36: 827.
  • 25
    National Board of Health and Welfare. Historical classifications. [Internet]. [cited 2011 December 18]. Available from: http://www.socialstyrelsen.se/klassificeringochkoder/diagnoskoder/historiska-klassifikationer.
  • 26
    WHO Collaborating Centre for Drug Statistics Methodology. The Anatomical Therapeutic Chemical (ATC) classification system. [Internet]. [cited 2011 December 18]. Available from: http://www.whocc.no/atc/structure_and_principles.
  • 27
    Slinin Y, Paudel ML, Taylor BC, Fink HA, Ishani A, Canales MT, Yaffe K, Barrett-Connor E, Orwoll ES, Shikany JM, LeBlanc ES, Cauley JA, Ensrud KE; for the Osteoporotic Fractures in Men Study Research Group. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology. 2010; 74: 3341.
  • 28
    Rönnemaa E, Zethelius B, Sundelöf J, Sundström J, Degerman-Gunnarsson M, Lannfelt L, Berne C, Kilander L. Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men. Diabetologia. 2009; 52: 150410.
  • 29
    Snellman G, Melhus H, Gedeborg R, Byberg L, Berglund L, Wernroth L, Michaelsson K. Determining vitamin D status: a comparison between commercially available assays. PLoS One. 2009; 5: e11555.
  • 30
    Michaëlsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med. 2003; 348: 28794.
  • 31
    Michaëlsson K, Lind L, Frystyk J, Flyvbjerg A, Gedeborg R, Berne C, Zethelius B, Mallmin H, Soderberg S, Melhus H. Serum adiponectin in elderly men does not correlate with fracture risk. J Clin Endocrinol Metab. 2008; 93: 40417.
  • 32
    Gedeborg R, Engquist H, Berglund L, Michaelsson K. Identification of incident injuries in hospital discharge registers. Epidemiology. 2008; 19: 8607.
  • 33
    Royston P. Explained variation for survival models. Stata J. 2006; 6: 8396.
  • 34
    Pencina MJ, D'Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011; 30: 1121.
  • 35
    Wald NJ, Morris JK. Assessing risk factors as potential screening tests: a simple assessment tool. Arch Intern Med. 2011; 171: 28691.
  • 36
    Pencina MJ, D'Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med. 2010; 48: 170311.
  • 37
    Sundström J, Byberg L, Gedeborg R, Michaëlsson K, Berglund L. Useful tests of usefulness of new risk factors: tools for assessing reclassification and discrimination. Scand J Publ Health. 2011; 39: 43941.
  • 38
    Hielscher T, Zucknick M, Werft W, Benner A. On the prognostic value of survival models with application to gene expression signatures. Stat Med. 2010; 29: 81829.
  • 39
    Engels JM, Diehr P. Imputation of missing longitudinal data: a comparison of methods. J Clin Epidemiol. 2003; 56: 96876.
  • 40
    Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, Rowe BH. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2009; CD007146.
  • 41
    Pit SW, Byles JE, Henry DA, Holt L, Hansen V, Bowman DA. A Quality Use of Medicines program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust. 2007; 187: 2330.
  • 42
    van der Velde N, Stricker BHC, Pols HAP, van der Cammen TJM. Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol. 2007; 63: 2327.
  • 43
    Gillespie WJ, Gillespie LD, Parker MJ. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev. 2010; CD001255.
  • 44
    Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing. 2010; 39: 2039.
  • 45
    Yun H, Delzell E, Ensrud KE, Kilgore ML, Becker D, Morrisey MA, Curtis JR. Predicting hip and major osteoporotic fractures using administrative data. Arch Intern Med. 2010; 170: 19402.
  • 46
    Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ. 2009; 339: b4229.
  • 47
    Collins GS, Mallett S, Altman DG. Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores. BMJ. 2011; 342: d3651.
  • 48
    Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011; 305: 218492.
  • 49
    Binkley N, Lewiecki EM. The evolution of fracture risk estimation. J Bone Miner Res. 2010; 25: 2098100.
  • 50
    Wagner H, Melhus H, Gedeborg R, Pedersen NL, Michaëlsson K. Simply ask them about their balance—future fracture risk in a nationwide cohort study of twins. Am J Epidemiol. 2009; 169: 1439.
  • 51
    Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse A. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20: 118594.
  • 52
    van Geel T, Huntjens K, van den Bergh J, Dinant G-J, Geusens P. Timing of subsequent fractures after an initial fracture. Curr Osteoporos Rep. 2010; 8: 11822.
  • 53
    Leslie WD, Majumdar SR, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; for the Manitoba Bone Density Program. High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int. Epub 2011 Mar 2. DOI: 10.1007/s00198-011-1592-3.
  • 54
    Lawless JF, Yuan Y. Estimation of prediction error for survival models. Stat Med. 2010; 29: 26274.
  • 55
    Donaldson MG, Cawthon PM, Schousboe JT, Ensrud KE, Lui L-Y, Cauley JA, Hillier TA, Taylor BC, Hochberg MC, Bauer DC, Cummings SR; Study of Osteoporotic Fractures (SOF). Novel methods to evaluate fracture risk models. J Bone Miner Res. 2011; 26: 176773.
  • 56
    Henderson R, Keiding N. Individual survival time prediction using statistical models. J Med Ethics. 2005; 31: 7036.
  • 57
    Johansson H. Estimation of risk in the field of osteoporosis. Gothenburg, Sweden: University of Gothenburg; 2011 April 15 [cited 2011 December 18]. Available from: http://hdl.handle.net/2077/24320.
  • 58
    Russell D, Stålhammar J, Bodegard J, Hasvold P, Thuresson M, Kjeldsen SE. Cardiovascular events in subgroups of patients during primary treatment of hypertension with candesartan or losartan. J Clin Hypertens. 2011; 13: 18997.